EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Disseminated paracoccidioidomycosis under biological therapy

Jaime A Ibarra-Burgos, Simón Correa-Sierra, Sergio A Londoño-Tabares

The Journal of Infection in Developing Countries · 2025

DOI: 10.3855/jidc.18939 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Jaime A Ibarra-Burgos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Internal medicine, Universidad CES Escuela de Medicina, Medellín, Colombia. Hauptthemen laut MEDLINE: Paracoccidioidomycosis, Paracoccidioides, Biological Therapy. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Paracoccidioidomycosis is an endemic mycotic infection caused by Paracoccidioides spp., prevalent in Central and South American countries. Anti-tumor necrosis factor (TNF) alpha agents, commonly used for autoimmune diseases, increase the risk of severe infections. We present a case of anti-TNF alpha-related paracoccidioidomycosis in a 71-year-old male farmer from Colombia. Case presentation: The patient had oral lesions and chronic cough. A biopsy showed granulomatous inflammation with multinucleated giant cells but no microorganisms. Negative microbiological stains and tests for other infections prompted further investigations. A positive serum immunodiffusion test for Paracoccidioides antibodies at a 1:256 titer led to mediastinoscopy and lung biopsy, which revealed budding yeast in a “captain’s wheel” formation. Treatment with liposomal amphotericin B and itraconazole was initiated.

Conclusions

This case highlights the risk of opportunistic infections under anti-TNF alpha therapy and raises awareness of paracoccidioidomycosis associations. Early diagnosis and management are essential for better patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ParacoccidioidomycosisParacoccidioidesBiological TherapyHumansMaleAgedAntifungal AgentsItraconazoleAmphotericin BColombiaTumor Necrosis Factor-alphaBiopsyAntibodies, Fungal

Stichwörter der Autor:innen

immunosuppressioninfectionsopportunisticparacoccidioidomycosis

Substanzen

Antifungal AgentsItraconazoleAmphotericin Bliposomal amphotericin BTumor Necrosis Factor-alphaAntibodies, Fungal

Autor:innen und Institutionen

  • Internal medicine, Universidad CES Escuela de Medicina, Medellín, Colombia.
  • Hospital Alma Mater de Antioquia, Clínica CES, Medellín, Colombia.

Zitieren

APA

Ibarra-Burgos, J. A., Correa-Sierra, S., & Londoño-Tabares, S. A. (2025). Disseminated paracoccidioidomycosis under biological therapy. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.18939

Vancouver

Ibarra-Burgos JA, Correa-Sierra S, Londoño-Tabares SA. Disseminated paracoccidioidomycosis under biological therapy. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.18939

BibTeX
@article{IbarraBurgos2025,
  author = {Ibarra-Burgos, Jaime A and Correa-Sierra, Simón and Londoño-Tabares, Sergio A},
  title = {Disseminated paracoccidioidomycosis under biological therapy},
  journal = {The Journal of Infection in Developing Countries},
  year = {2025},
  doi = {10.3855/jidc.18939}
}
Kostenlos starten →